{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:20:38Z","timestamp":1792549238547,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1192"],"award-info":[{"award-number":["SFB1192"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1192"],"award-info":[{"award-number":["SFB1192"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1192"],"award-info":[{"award-number":["SFB1192"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Antineutrophil cytoplasmic antibody (ANCA)\u2013associated vasculitis is a life-threatening autoimmune disease that often results in kidney failure caused by crescentic glomerulonephritis (GN). To date, treatment of most patients with ANCA-GN relies on non-specific immunosuppressive agents, which may have serious adverse effects and be only partially effective. Here, using spatial and single-cell transcriptome analysis, we characterize inflammatory niches in kidney samples from 34 patients with ANCA-GN and identify proinflammatory, cytokine-producing CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> T cells as a pathogenic signature. We then utilize these transcriptomic profiles for digital pharmacology and identify ustekinumab, a monoclonal antibody targeting IL-12 and IL-23, as the strongest therapeutic drug to use. Moreover, four patients with relapsing ANCA-GN are treated with ustekinumab in combination with low-dose cyclophosphamide and steroids, with ustekinumab given subcutaneously (90\u2009mg) at weeks 0, 4, 12, and 24. Patients are followed up for 26 weeks to find this treatment well-tolerated and inducing clinical responses, including improved kidney function and Birmingham Vasculitis Activity Score, in all ANCA-GN patients. Our findings thus suggest that targeting of pathogenic T cells in ANCA-GN patients with ustekinumab might represent a potential approach and warrants further investigation in clinical trials.<\/jats:p>","DOI":"10.1038\/s41467-024-52525-w","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T07:02:52Z","timestamp":1726729372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Immune profiling-based targeting of pathogenic T cells with ustekinumab in ANCA-associated glomerulonephritis"],"prefix":"10.1038","volume":"15","author":[{"given":"Jonas","family":"Engesser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5311-1718","authenticated-orcid":false,"given":"Robin","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius P.","family":"Schaub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2632-7530","authenticated-orcid":false,"given":"Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Joachim","family":"Paust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6610-9955","authenticated-orcid":false,"given":"Zeba","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nariaki","family":"Asada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Hendrik","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varshi","family":"Sivayoganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anett","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kaffke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6739-3051","authenticated-orcid":false,"given":"Saskia-Larissa","family":"Jauch-Speer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago","family":"Goldbeck-Strieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor G.","family":"Puelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0116-255X","authenticated-orcid":false,"given":"Ulrich O.","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5142-328X","authenticated-orcid":false,"given":"Oliver M.","family":"Steinmetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elion","family":"Hoxha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1677-5455","authenticated-orcid":false,"given":"Jan-Eric","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6166-4191","authenticated-orcid":false,"given":"Hans-Willi","family":"Mittr\u00fccker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4053-1474","authenticated-orcid":false,"given":"Thorsten","family":"Wiech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7175-5062","authenticated-orcid":false,"given":"Tobias B.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Bonn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2739-5578","authenticated-orcid":false,"given":"Christian F.","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9449-0722","authenticated-orcid":false,"given":"Ulf","family":"Panzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,19]]},"reference":[{"key":"52525_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","volume":"6","author":"AR Kitching","year":"2020","unstructured":"Kitching, A. R. et al. ANCA-associated vasculitis. Nat. Rev. Dis. Prim. 6, 71 (2020).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"52525_CR2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41577-022-00816-y","volume":"23","author":"H-J Anders","year":"2023","unstructured":"Anders, H.-J., Kitching, A. R., Leung, N. & Romagnani, P. Glomerulonephritis. Immunopathogenesis and immunotherapy. Nat. Rev. Immunol. 23, 453\u2013471 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"52525_CR3","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nri3523","volume":"13","author":"C Kurts","year":"2013","unstructured":"Kurts, C., Panzer, U., Anders, H.-J. & Rees, A. J. The immune system and kidney disease. Basic concepts and clinical implications. Nat. Rev. Immunol. 13, 738\u2013753 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"52525_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/ki.2010.472","volume":"79","author":"B Wilde","year":"2011","unstructured":"Wilde, B., van Paassen, P., Witzke, O. & Tervaert, J. W. C. New pathophysiological insights and treatment of ANCA-associated vasculitis. Kidney Int. 79, 599\u2013612 (2011).","journal-title":"Kidney Int."},{"key":"52525_CR5","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","volume":"371","author":"L Guillevin","year":"2014","unstructured":"Guillevin, L. et al. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N. Engl. J. Med. 371, 1771\u20131780 (2014).","journal-title":"N. Engl. J. Med."},{"key":"52525_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1213277","volume":"369","author":"U Specks","year":"2013","unstructured":"Specks, U. et al. Efficacy of remission-induction regimens for ANCA-associated vasculitis. N. Engl. J. Med. 369, 417\u2013427 (2013).","journal-title":"N. Engl. J. Med."},{"key":"52525_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone, J. H. et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N. Engl. J. Med. 363, 221\u2013232 (2010).","journal-title":"N. Engl. J. Med."},{"key":"52525_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa2023386","volume":"384","author":"DRW Jayne","year":"2021","unstructured":"Jayne, D. R. W., Merkel, P. A., Schall, T. J. & Bekker, P. Avacopan for the treatment of ANCA-associated vasculitis. N. Engl. J. Med. 384, 599\u2013609 (2021).","journal-title":"N. Engl. J. Med."},{"key":"52525_CR9","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1136\/ard.2009.108043","volume":"69","author":"PA Lyons","year":"2010","unstructured":"Lyons, P. A. et al. Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis. Ann. Rheum. Dis. 69, 1208\u20131213 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"52525_CR10","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1002\/art.39153","volume":"67","author":"PC Grayson","year":"2015","unstructured":"Grayson, P. C. et al. Neutrophil-related gene expression and low-density granulocytes associated with disease activity and response to treatment in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol. 67, 1922\u20131932 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"52525_CR11","doi-asserted-by":"publisher","first-page":"1072598","DOI":"10.3389\/fimmu.2023.1072598","volume":"14","author":"A Banos","year":"2023","unstructured":"Banos, A. et al. The genomic landscape of ANCA-associated vasculitis. Distinct transcriptional signatures, molecular endotypes and comparison with systemic lupus erythematosus. Front. Immunol. 14, 1072598 (2023).","journal-title":"Front. Immunol."},{"key":"52525_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41328-0","volume":"14","author":"M Nishide","year":"2023","unstructured":"Nishide, M. et al. Single-cell multi-omics analysis identifies two distinct phenotypes of newly-onset microscopic polyangiitis. Nat. Commun. 14, 5789 (2023).","journal-title":"Nat. Commun."},{"key":"52525_CR13","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1681\/ASN.2015050511","volume":"27","author":"VP O\u2019Reilly","year":"2016","unstructured":"O\u2019Reilly, V. P. et al. Urinary soluble CD163 in active renal vasculitis. J. Am. Soc. Nephrol. 27, 2906\u20132916 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"52525_CR14","doi-asserted-by":"publisher","first-page":"eaba4163","DOI":"10.1126\/sciimmunol.aba4163","volume":"5","author":"CF Krebs","year":"2020","unstructured":"Krebs, C. F. et al. Pathogen-induced tissue-resident memory TH17 (TRM17) cells amplify autoimmune kidney disease. Sci. Immunol. 5, eaba4163 (2020).","journal-title":"Sci. Immunol."},{"key":"52525_CR15","doi-asserted-by":"publisher","first-page":"eadd6137","DOI":"10.1126\/scitranslmed.add6137","volume":"15","author":"H-J Paust","year":"2023","unstructured":"Paust, H.-J. et al. CD4+ T cells produce GM-CSF and drive immune-mediated glomerular disease by licensing monocyte-derived cells to produce MMP12. Sci. Transl. Med. 15, eadd6137 (2023).","journal-title":"Sci. Transl. Med."},{"key":"52525_CR16","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.kint.2018.07.020","volume":"94","author":"SR Brix","year":"2018","unstructured":"Brix, S. R. et al. Development and validation of a renal risk score in ANCA-associated glomerulonephritis. Kidney Int. 94, 1177\u20131188 (2018).","journal-title":"Kidney Int."},{"key":"52525_CR17","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41586-023-05769-3","volume":"619","author":"BB Lake","year":"2023","unstructured":"Lake, B. B. et al. An atlas of healthy and injured cell states and niches in the human kidney. Nature 619, 585\u2013594 (2023).","journal-title":"Nature"},{"key":"52525_CR18","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nature10957","volume":"484","author":"CE Zielinski","year":"2012","unstructured":"Zielinski, C. E. et al. Pathogen-induced human TH17 cells produce IFN-\u03b3 or IL-10 and are regulated by IL-1\u03b2. Nature 484, 514\u2013518 (2012).","journal-title":"Nature"},{"key":"52525_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa0909169","volume":"363","author":"RB Jones","year":"2010","unstructured":"Jones, R. B. et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N. Engl. J. Med. 363, 211\u2013220 (2010).","journal-title":"N. Engl. J. Med."},{"key":"52525_CR20","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1056\/NEJMoa1803537","volume":"382","author":"M Walsh","year":"2020","unstructured":"Walsh, M. et al. Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N. Engl. J. Med. 382, 622\u2013631 (2020).","journal-title":"N. Engl. J. Med."},{"key":"52525_CR21","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1136\/annrheumdis-2016-210942","volume":"76","author":"JA Tan","year":"2017","unstructured":"Tan, J. A. et al. Mortality in ANCA-associated vasculitis. A meta-analysis of observational studies. Ann. Rheum. Dis. 76, 1566\u20131574 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"52525_CR22","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/ard.2010.137778","volume":"70","author":"O Flossmann","year":"2011","unstructured":"Flossmann, O. et al. Long-term patient survival in ANCA-associated vasculitis. Ann. Rheum. Dis. 70, 488\u2013494 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"52525_CR23","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/ndt\/gfac320","volume":"38","author":"B S\u00e1nchez \u00c1lamo","year":"2023","unstructured":"S\u00e1nchez \u00c1lamo, B. et al. Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis. Nephrol. Dial. Transplant. 38, 1655\u20131665 (2023).","journal-title":"Nephrol. Dial. Transplant."},{"key":"52525_CR24","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1136\/ard.2007.077693","volume":"67","author":"M Heckmann","year":"2008","unstructured":"Heckmann, M. et al. The Wegener\u2019s granulomatosis quantitative trait locus on chromosome 6p21.3 as characterised by tagSNP genotyping. Ann. Rheum. Dis. 67, 972\u2013979 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"52525_CR25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1056\/NEJMoa1108735","volume":"367","author":"PA Lyons","year":"2012","unstructured":"Lyons, P. A. et al. Genetically distinct subsets within ANCA-associated vasculitis. N. Engl. J. Med. 367, 214\u2013223 (2012).","journal-title":"N. Engl. J. Med."},{"key":"52525_CR26","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.kint.2019.06.015","volume":"96","author":"H-Y Wang","year":"2019","unstructured":"Wang, H.-Y. et al. Risk HLA class II alleles and amino acid residues in myeloperoxidase-ANCA-associated vasculitis. Kidney Int. 96, 1010\u20131019 (2019).","journal-title":"Kidney Int."},{"key":"52525_CR27","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/nm.2130","volume":"16","author":"EF McKinney","year":"2010","unstructured":"McKinney, E. F. et al. A CD8+ T cell transcription signature predicts prognosis in autoimmune disease. Nat. Med. 16, 586 (2010).","journal-title":"Nat. Med."},{"key":"52525_CR28","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1002\/art.24747","volume":"60","author":"WH Abdulahad","year":"2009","unstructured":"Abdulahad, W. H., Kallenberg, C. G. M., Limburg, P. C. & Stegeman, C. A. Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 60, 2830\u20132838 (2009).","journal-title":"Arthritis Rheum."},{"key":"52525_CR29","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1093\/ndt\/gfp783","volume":"25","author":"E Nogueira","year":"2010","unstructured":"Nogueira, E. et al. Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. Nephrol. Dial. Transplant. 25, 2209\u20132217 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"52525_CR30","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/j.1523-1755.2004.00534.x","volume":"65","author":"WH Schmitt","year":"2004","unstructured":"Schmitt, W. H. et al. Treatment of refractory Wegener\u2019s granulomatosis with antithymocyte globulin (ATG). An open study in 15 patients. Kidney Int. 65, 1440\u20131448 (2004).","journal-title":"Kidney Int."},{"key":"52525_CR31","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1056\/NEJMoa0810652","volume":"362","author":"CEM Griffiths","year":"2010","unstructured":"Griffiths, C. E. M. et al. Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. N. Engl. J. Med. 362, 118\u2013128 (2010).","journal-title":"N. Engl. J. Med."},{"key":"52525_CR32","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0140-6736(09)60140-9","volume":"373","author":"A Gottlieb","year":"2009","unstructured":"Gottlieb, A. et al. Ustekinumab, a human interleukin 12\/23 monoclonal antibody, for psoriatic arthritis. Randomised, double-blind, placebo-controlled, crossover trial. Lancet 373, 633\u2013640 (2009).","journal-title":"Lancet"},{"key":"52525_CR33","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1056\/NEJMoa1602773","volume":"375","author":"BG Feagan","year":"2016","unstructured":"Feagan, B. G. et al. Ustekinumab as induction and maintenance therapy for Crohn\u2019s disease. N. Engl. J. Med. 375, 1946\u20131960 (2016).","journal-title":"N. Engl. J. Med."},{"key":"52525_CR34","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMoa1900750","volume":"381","author":"BE Sands","year":"2019","unstructured":"Sands, B. E. et al. Ustekinumab as induction and maintenance therapy for ulcerative colitis. N. Engl. J. Med. 381, 1201\u20131214 (2019).","journal-title":"N. Engl. J. Med."},{"key":"52525_CR35","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1002\/acr.24630","volume":"74","author":"Y Jin","year":"2022","unstructured":"Jin, Y. et al. Risk of hospitalization for serious infection after initiation of ustekinumab or other biologics in patients with psoriasis or psoriatic arthritis. Arthritis Care Res. 74, 1792\u20131805 (2022).","journal-title":"Arthritis Care Res."},{"key":"52525_CR36","first-page":"706","volume":"14","author":"K Papp","year":"2015","unstructured":"Papp, K. et al. Safety surveillance for ustekinumab and other psoriasis treatments from the psoriasis longitudinal assessment and registry (PSOLAR). J. Drugs Dermatol. 14, 706\u2013714 (2015).","journal-title":"J. Drugs Dermatol."},{"key":"52525_CR37","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s40264-019-00797-3","volume":"42","author":"S Ghosh","year":"2019","unstructured":"Ghosh, S. et al. Ustekinumab safety in psoriasis, psoriatic arthritis, and Crohn\u2019s disease. An integrated analysis of phase II\/III clinical development programs. Drug Saf. 42, 751\u2013768 (2019).","journal-title":"Drug Saf."},{"key":"52525_CR38","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1136\/annrheumdis-2013-204655","volume":"73","author":"C Ritchlin","year":"2014","unstructured":"Ritchlin, C. et al. Efficacy and safety of the anti-IL-12\/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy. 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial. Ann. Rheum. Dis. 73, 990\u2013999 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"52525_CR39","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/S0140-6736(13)60594-2","volume":"382","author":"IB McInnes","year":"2013","unstructured":"McInnes, I. B. et al. Efficacy and safety of ustekinumab in patients with active psoriatic arthritis. 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial. Lancet 382, 780\u2013789 (2013).","journal-title":"Lancet"},{"key":"52525_CR40","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/S0140-6736(18)32167-6","volume":"392","author":"RF van Vollenhoven","year":"2018","unstructured":"van Vollenhoven, R. F. et al. Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus. Results of a multicentre, double-blind, phase 2, randomised, controlled study. Lancet 392, 1330\u20131339 (2018).","journal-title":"Lancet"},{"key":"52525_CR41","doi-asserted-by":"publisher","first-page":"e142428","DOI":"10.1172\/JCI142428","volume":"131","author":"H Li","year":"2021","unstructured":"Li, H. et al. IL-23 reshapes kidney resident cell metabolism and promotes local kidney inflammation. J. Clin. Investig. 131, e142428 (2021).","journal-title":"J. Clin. Investig."},{"key":"52525_CR42","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.kint.2019.05.012","volume":"96","author":"P-Y Gan","year":"2019","unstructured":"Gan, P.-Y. et al. Biologicals targeting T helper cell subset differentiating cytokines are effective in the treatment of murine anti-myeloperoxidase glomerulonephritis. Kidney Int. 96, 1121\u20131133 (2019).","journal-title":"Kidney Int."},{"key":"52525_CR43","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1681\/ASN.V104752","volume":"10","author":"AR Kitching","year":"1999","unstructured":"Kitching, A. R., Holdsworth, S. R. & Tipping, P. G. IFN-gamma mediates crescent formation and cell-mediated immune injury in murine glomerulonephritis. J. Am. Soc. Nephrol. 10, 752\u2013759 (1999).","journal-title":"J. Am. Soc. Nephrol."},{"key":"52525_CR44","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1681\/ASN.2008050556","volume":"20","author":"H-J Paust","year":"2009","unstructured":"Paust, H.-J. et al. The IL-23\/Th17 axis contributes to renal injury in experimental glomerulonephritis. J. Am. Soc. Nephrol. 20, 969\u2013979 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"52525_CR45","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1681\/ASN.2019090879","volume":"31","author":"A Schreiber","year":"2020","unstructured":"Schreiber, A. et al. Neutrophil gelatinase-associated lipocalin protects from ANCA-induced GN by inhibiting TH17 immunity. J. Am. Soc. Nephrol. 31, 1569\u20131584 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"52525_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY. Large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).","journal-title":"Genome Biol."},{"key":"52525_CR47","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"52525_CR48","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41592-021-01358-2","volume":"19","author":"G Palla","year":"2022","unstructured":"Palla, G. et al. Squidpy. A scalable framework for spatial omics analysis. Nat. Methods 19, 171\u2013178 (2022).","journal-title":"Nat. Methods"},{"key":"52525_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25957-x","volume":"12","author":"JB Kang","year":"2021","unstructured":"Kang, J. B. et al. Efficient and precise single-cell reference atlas mapping with Symphony. Nat. Commun. 12, 5890 (2021).","journal-title":"Nat. Commun."},{"key":"52525_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27150-6","volume":"12","author":"M B\u00fcttner","year":"2021","unstructured":"B\u00fcttner, M., Ostner, J., M\u00fcller, C. L., Theis, F. J. & Schubert, B. scCODA is a Bayesian model for compositional single-cell data analysis. Nat. Commun. 12, 6876 (2021).","journal-title":"Nat. Commun."},{"key":"52525_CR51","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L.-G., Han, Y. & He, Q.-Y. clusterProfiler. An R package for comparing biological themes among gene clusters. Omics J. Integr. Biol. 16, 284\u2013287 (2012).","journal-title":"Omics J. Integr. Biol."},{"key":"52525_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA. Gene set variation analysis for microarray and RNA-seq data. BMC Bioinforma. 14, 7 (2013).","journal-title":"BMC Bioinforma."},{"key":"52525_CR53","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e29 (2021).","journal-title":"Cell"},{"key":"52525_CR54","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41592-020-01050-x","volume":"18","author":"A Gayoso","year":"2021","unstructured":"Gayoso, A. et al. Joint probabilistic modeling of single-cell multi-omic data with totalVI. Nat. Methods 18, 272\u2013282 (2021).","journal-title":"Nat. Methods"},{"key":"52525_CR55","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1126\/science.aat5031","volume":"365","author":"BJ Stewart","year":"2019","unstructured":"Stewart, B. J. et al. Spatiotemporal immune zonation of the human kidney. Science 365, 1461\u20131466 (2019).","journal-title":"Science"},{"key":"52525_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-024-03251-5","volume":"25","author":"R Khatri","year":"2024","unstructured":"Khatri, R., Machart, P. & Bonn, S. DISSECT. Deep semi-supervised consistency regularization for accurate cell type fraction and gene expression estimation. Genome Biol. 25, 112 (2024).","journal-title":"Genome Biol."},{"key":"52525_CR57","doi-asserted-by":"publisher","first-page":"D930","DOI":"10.1093\/nar\/gky1075","volume":"47","author":"D Mendez","year":"2019","unstructured":"Mendez, D. et al. ChEMBL. Towards direct deposition of bioassay data. Nucleic Acids Res. 47, D930\u2013D940 (2019).","journal-title":"Nucleic Acids Res."},{"key":"52525_CR58","doi-asserted-by":"publisher","first-page":"D1144","DOI":"10.1093\/nar\/gkaa1084","volume":"49","author":"SL Freshour","year":"2021","unstructured":"Freshour, S. L. et al. Integration of the drug-gene interaction database (DGIdb 4.0) with open crowdsource efforts. Nucleic Acids Res. 49, D1144\u2013D1151 (2021).","journal-title":"Nucleic Acids Res."},{"key":"52525_CR59","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/s41586-023-06311-1","volume":"619","author":"K Kanemaru","year":"2023","unstructured":"Kanemaru, K. et al. Spatially resolved multiomics of human cardiac niches. Nature 619, 801\u2013810 (2023).","journal-title":"Nature"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52525-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52525-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52525-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T08:06:21Z","timestamp":1726733181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52525-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["52525"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-52525-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,19]]},"assertion":[{"value":"14 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8220"}}